enterobacter aerogenes atcc 13048 e a (ATCC)
ATCC is a verified supplier 
ATCC manufactures this product 
96
Structured Review
ATCC
enterobacter aerogenes atcc 13048 e a
Enterobacter Aerogenes Atcc 13048 E A, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 609 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterobacter+aerogenes+atcc+13048+e+a/Enterobacter+aerogenes/pm41784439-237-4-6
Average 96 stars, based on 609 article reviews
Enterobacter Aerogenes Atcc 13048 E A, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 609 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/enterobacter+aerogenes+atcc+13048+e+a/Enterobacter+aerogenes/pm41784439-237-4-6
Average 96 stars, based on 609 article reviews
enterobacter aerogenes atcc 13048 e a - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
other:Article Title: Microorganism microneedle micro-engine depth drug delivery Article Snippet: By encapsulating active gas-producing microorganisms, specifically Article Title: Disease-tailored drug delivery microneedle systems: Precision engineering for unmet clinical needs. Article Snippet: Microneedles, as a painless and minimally invasive transdermal drug delivery tool, are an attractive alternative to conventional administration routes such as oral and injectable methods.. However, each diseases have a particular microenvironment with well-defined characteristics, which promotes deeper selection criteria of microneedles to meet the disease needs.. Recent advances, encompassing bioinspired designs, piezoelectric actuation, stimuli-responsive materials, and gas-propelled systems, have transformed microneedles from passive administration into intelligent, multifunctional therapeutic platforms. Produced:Article Title: Live bacteria microneedles for biomedical applications. Article Snippet: Bacteria play dual roles as both pathogenic agents and therapeutic agents.. Their inherent motility, tumor-preferential colonization, and immunomodulatory properties confer significant disease prevention and treatment potential in fields such as intestinal therapy, oncology, and wound healing.. However, challenges including bacterial biosafety concerns, delivery methods, and low colonization rates severely hinder their biomedical and clinical applications in disease treatment. |